文献速递乳腺癌胸部肿瘤

浸润性乳腺癌放射治疗增加第二原发肺癌风险:一项全国性人群队列分析

Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis.
PubMed 文献 · J Thorac Oncol · 2017-02-15

该全国性人群队列分析纳入2000至2010年986713名个体,最终7408例新诊断浸润性乳腺癌患者符合标准,分为放疗组5695例和非放疗组1713例。放疗组128例(2.25%)发生肺癌,非放疗组仅4例(0.23%),Cox回归显示放疗组调整风险比是非放疗组的10.078倍。结论认为既往乳腺癌放疗者第二原发肺癌发生率显著更高,应广泛随访评估后续肺癌发生。

要点

  • 乳腺癌放疗组第二原发肺癌发生率为2.25%(128/5695),非放疗组为0.23%(4/1713)。
  • Cox回归显示放疗组较非放疗组调整风险比为10.078。
  • 作者认为接受放疗的乳腺癌患者应广泛随访以评估后续肺癌发生。

核心结论

  • 对于既往乳腺癌患者,放疗组第二原发肺癌发生率显著高于非放疗组。
  • 作者认为接受放疗的乳腺癌患者应广泛随访以评估后续肺癌的发生。

研究设计与样本

  • 基于 Longitudinal Health Insurance Database 的全国性人群队列分析,从2000至2010年随机纳入986713名个体。
  • 纳入新诊断浸润性乳腺癌、年龄18岁及以上、2000年前及随访期间无其他恶性肿瘤的女性,分配至放疗组或非放疗组。
  • 分析年龄、合并症、保费、城市化水平、地区、事件日期和医院护理等级,采用 Cox 回归计算风险比。

主要发现

  • 共7408例符合纳入标准,其中放疗组5695例,非放疗组1713例。
  • 放疗组128例(2.25%)发生肺癌,非放疗组随访期间仅4例(0.23%)诊断肺癌。
  • Cox 回归分析显示,既往乳腺癌患者中放疗组较非放疗组的调整风险比为10.078。

临床怎么用

  • 作者认为接受放疗的乳腺癌患者应广泛随访以评估后续肺癌的发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Although the risk factors for lung cancer are well documented, whether previous radiation therapy (RT) to treat breast cancer (BC) increases the incidence of second primary lung cancer remains unclear. We determined the overall incidence of second primary lung cancer after previous RT for all clinical stages of BC. METHODS: After an analysis of the Longitudinal Health Insurance Database, 986,713 individuals were randomly enrolled from 2000 to 2010 for cohort analysis. All women with newly diagnosed invasive BC, aged 18 years or older, and without other types of malignancy before 2000 or in the follow-up periods were enrolled and allocated to the RT or non-RT groups. Age, comorbidities, insurance premium, urbanization level, location, date of event, and hospital care level were analyzed. The hazard ratios of parameters were calculated by Cox regression analysis. RESULTS: A total of 7408 individuals met the inclusion criteria, including 5695 patients with BC who underwent RT and 128 (2.25%) in whom lung cancer developed. In contrast, lung cancer was diagnosed in only four of 1713 individuals in the non-RT group (0.23%) during the follow-up period. Cox regression analysis showed that the adjusted hazard ratio was 10.078 times higher in the RT group than in the non-RT group for individuals with previous BC. CONCLUSIONS: The incidence of second primary lung cancer was significantly higher in the RT group than in the non-RT group for individuals with previous BC. Patients with BC treated by RT should be extensively surveyed to assess the incidence of subsequent lung cancer.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Huang YJ, Huang TW, Lin FH, et al. Radiation Therapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer: A Nationwide Population-Based Cohort Analysis. J Thorac Oncol. 2017. PMID: 28214559. doi:10.1016/j.jtho.2017.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。